BETA

BLUF is in public beta. Automated sourcing and summaries by the BLUF engine, monitored by our team. Summaries may contain errors — verify important details at the source. Not medical, legal or financial advice. Public beta — automated summaries may contain errors. Full disclaimer

ARCHIVEARCHIVED EVENT BRIEFLAST CHANGED
ECONOMY • IRELAND

Steris to acquire Xodus Medical for $2.1 billion

1 OUTLET · 2 REPORTS IRELANDARCHIVED
HISTORICAL RECORD

This event has left the current brief. The summary below describes the stored record; open the original sources for current conditions.

BLUF

Steris agreed to acquire Xodus Medical for $2.1 billion, according to The Wall Street Journal. Xodus, based in Dublin, provides products and services to hospitals and pharmaceutical manufacturers; Steris expects the deal to expand its portfolio.

WHAT IS VERIFIED — AND WHAT IS NOT

Source coverage is not proof of every claim. Confirmed means direct support from an official record; corroborated means matching reporting; reported means attributed but not independently verified here. Disputed details remain unresolved.

REPORTED

Steris is acquiring Xodus Medical for $2.1 billion.

The Wall Street JournalThe Wall Street Journal
REPORTED

Xodus Medical provides products and services to hospitals and pharmaceutical manufacturers and is based in Dublin.

The Wall Street JournalThe Wall Street Journal
REPORTED

Steris expects the acquisition to expand its portfolio.

The Wall Street JournalThe Wall Street Journal
WHO'S COVERING IT

HOW THIS BRIEF WAS MADE 1 outlet: 1 national. Automated sourcing and summaries by the BLUF engine. Corrections

CONFIDENCE: LOW · SOURCE GRADE B6Coverage from 1 independent outlet; no official record is among BLUF's sources yet; officials may be quoted in the reporting. Coverage breadth does not verify every claim; see claim-level sources. What B6 means

Why it matters

The acquisition concerns suppliers serving hospitals and pharmaceutical manufacturers, but the report does not detail effects on U.S. customers, prices or operations.

The rest of this brief is for BLUF readers with a plan
  • The full picture: every consequence, and the dates and decisions to watch
  • Timeline of how the story developed
  • How 1 outlets cover it, side by side (2 reports)
  • Claims and evidence: what's confirmed, reported or disputed
  • Background and Ask BLUF questions about this story

Plus gives you unlimited full stories for $8 a month. See plans Already have a plan? Sign in.